UK markets close in 5 hours 37 minutes
  • FTSE 100

    7,239.61
    -198.48 (-2.67%)
     
  • FTSE 250

    19,405.74
    -543.70 (-2.73%)
     
  • AIM

    938.65
    -14.30 (-1.50%)
     
  • GBP/EUR

    1.1808
    +0.0019 (+0.16%)
     
  • GBP/USD

    1.2390
    +0.0048 (+0.39%)
     
  • BTC-GBP

    23,374.56
    -898.12 (-3.70%)
     
  • CMC Crypto 200

    643.44
    -27.23 (-4.06%)
     
  • S&P 500

    3,923.68
    -165.17 (-4.04%)
     
  • DOW

    31,490.07
    -1,164.52 (-3.57%)
     
  • CRUDE OIL

    107.72
    -1.87 (-1.71%)
     
  • GOLD FUTURES

    1,824.00
    +8.10 (+0.45%)
     
  • NIKKEI 225

    26,402.84
    -508.36 (-1.89%)
     
  • HANG SENG

    20,120.68
    -523.60 (-2.54%)
     
  • DAX

    13,703.45
    -304.31 (-2.17%)
     
  • CAC 40

    6,205.33
    -147.61 (-2.32%)
     

Molecular Diagnostics: Technologies and Global Markets

·2-min read
ReportLinker
ReportLinker

Report Scope: This study examines the global market for assays used to detect specific nucleic acid sequences in medical and life science applications. The goal of all DNA-based diagnostic assays is similar, but several different technologies can be employed.

New York, April 18, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Molecular Diagnostics: Technologies and Global Markets" - https://www.reportlinker.com/p01140654/?utm_source=GNW


The analyst analyzes each technology in detail, determines major players and current market status, and presents forecasts of growth over the next five years.Scientific challenges and advances, including the latest trends, are emphasized.

Government regulations, major collaborations, recent patents and factors affecting the industry from a global perspective are examined. New directions for DNA diagnostic technologies and emerging applications in clinical diagnostics are also examined.

Key molecular diagnostic technologies and products are analyzed to determine present and future market status, and growth is forecast from 2021 to 2026. In-depth discussion of strategic alliances, industry structures, competitive dynamics, patents and market driving forces are also provided.

Report Includes:
- 60 tables
- An overview of the global market and technologies for molecular diagnostics
- Estimation of the market size and analyses of global market trends, with data from 2019 to 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Characterization and quantification of market potential for molecular diagnostic technologies by technology, application and region
- Information about food and drug administration guidelines and internal standards for DNA diagnostics, and coverage of novel therapeutic products and their approvals
- Discussion on related issues, government regulations, and reimbursement through insurance, patient confidentiality and other legal ramifications
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size and forecast
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players, including Abbott, Becton, Dickinson and Company, General Electric, Siemens Healthcare GmbH and Thermo Fisher Scientific Inc.

Summary:
The global market for molecular diagnosticswas valued at REDACTED in 2020. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach approximately REDACTED by 2026.

Medical device companies, both industry giants and startups, are significantly investing in research and development (R&D) to develop innovative diagnosticproducts that can manage a host ofmedical conditions, including obesity, sleep apnea, diabetes,chronicobstructive pulmonary disease (COPD), asthmaand cardiac diseases, aswell as disability rehabilitation and the monitoring of progressive nervous systemdisorders, such as Parkinson’s disease.

The increasing prevalence of diseases requiring round-the-clockmonitoring is an important driverof the market, and it is expected to significantly contribute to the industry’s double-digit growth, especially considering the increase in the global geriatric population. Technological advancements are also promoting the adoption of many diagnostic products.
Read the full report: https://www.reportlinker.com/p01140654/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting